Top search result for "behavioral changes and parkinsons" in Treatments. To see all results and access other features, sign up for free.

Crexont (Carbidopa and Levodopa)

Overview
Crexont is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson’s disease, post-encephalitic parkinsonism (Parkinson-like symptoms following brain inflammation), and parkinsonism…